Spero Therapeutics, Inc.SPRONASDAQ
Loading
Total revenue from sales of goods and services
3Y CAGR
-9.7%/yr
vs +87.1%/yr prior
5Y CAGR
+30.8%/yr
Recent deceleration
Acceleration
-96.8pp
Decelerating
Percentile
P70
Within normal range
vs 5Y Ago
3.8x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $35.77M | -25.4% |
| 2024 | $47.98M | -53.8% |
| 2023 | $103.78M | +113.6% |
| 2022 | $48.58M | +1482.4% |
| 2021 | $3.07M | -67.1% |
| 2020 | $9.33M | -48.6% |
| 2019 | $18.15M | +357.6% |
| 2018 | $3.97M | +100.4% |
| 2017 | $1.98M | +490.7% |
| 2016 | $335000.00 | - |